Paper Details 
Original Abstract of the Article :
Secondary hyperparathyroidism may manifest as hypercalcemia in the post-transplant period. The classical treatment method is parathyroidectomy and the alternative is oral cinacalcet, a calcimimetic agent therapy. We retrospectively investigated the effect of cinacalcet therapy on kidney and patient ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105616/

データ提供:米国国立医学図書館(NLM)

Managing Hypercalcemia and Hyperparathyroidism after Kidney Transplantation: A Single-Center Experience

Kidney transplantation is a life-saving procedure for individuals with end-stage renal disease, but it can sometimes lead to complications such as hypercalcemia and hyperparathyroidism. This research explores the effectiveness of cinacalcet, a calcimimetic agent, in managing these complications after kidney transplantation. The study examines the impact of cinacalcet therapy on kidney and patient survival in a single-center experience.

Cinacalcet: A Potential Solution for Post-Transplant Complications

The researchers found that cinacalcet therapy was effective in managing hypercalcemia and hyperparathyroidism after kidney transplantation, with no significant adverse effects on kidney or patient survival. The study highlights the potential of cinacalcet as a valuable therapeutic option for managing these complications.

The Importance of Post-Transplant Management

This research emphasizes the importance of managing post-transplant complications to ensure long-term success after kidney transplantation. Imagine a vast desert oasis, where the transplanted kidney is a precious resource. Careful post-transplant management is crucial to protect this resource and ensure its longevity, providing a sustainable source of health and vitality for the recipient.

Dr. Camel's Conclusion

This research explores the use of cinacalcet in managing hypercalcemia and hyperparathyroidism after kidney transplantation. The findings highlight the potential of this medication as a valuable tool for managing these post-transplant complications, improving the long-term health and well-being of kidney transplant recipients. This research serves as a reminder that the journey to a successful kidney transplant is a long and multifaceted one, requiring dedicated care and monitoring to ensure long-term success.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-04-19
Further Info :

Pubmed ID

37069889

DOI: Digital Object Identifier

PMC10105616

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.